Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome

February 8, 2024 updated by: University of Kansas Medical Center
The purpose of this study is to learn whether or not certain risk factors and patient characteristics are linked with and possibly can predict the development of chronic pain after lumbar spine surgery.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

158

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Andrea Nicol, MD
  • Phone Number: (913) 588-9900
  • Email: anicol@kumc.edu

Study Locations

    • Kansas
      • Kansas City, Kansas, United States, 66160
        • University of Kansas Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Participants will be recruited directly by the Candidate and by referral from specialist physicians at the KUMC Marc A. Asher, MD, Comprehensive Spine and Pain Management Center.

Description

Inclusion Criteria For All Participants:

  • Ability to read and speak English to allow for written informed consent, phenotyping, and patient-reported outcomes measures

Exclusion Criteria For All Participants:

  • Individuals receiving or applying for compensation or disability and other aspects associated with potential secondary gain
  • Inability to provide written informed consent
  • Severe physical impairment
  • Co-morbid medical conditions that may significantly impair physical functional status
  • Illicit drug or unreported opioid use
  • Medical or psychiatric conditions that in the judgment of study personnel would preclude participation in this study
  • Pregnant or nursing
  • Liver failure
  • Self-reported liver cirrhosis
  • Self-reported hepatitis
  • Severe Cardiovascular disease

Inclusion Criteria for Candidates for Lumbar Spine Surgery:

  • Deemed to be a candidate for primary lumbar spine surgery including but not limited to: lumbar laminectomy, discectomy, and fusion/instrumentation
  • Diagnostic clinical and radiographic findings including but not limited to: lumbar degenerative disc disease, lumbar disc protrusion, herniation, or extrusion, lumbar spondylosis, lumbar spinal stenosis, lumbar spondylolisthesis or spondylolysis
  • Willingness to participate in longitudinal follow-up or 6-months after their surgery.

Exclusion Criteria for Candidates for Lumbar Spine Surgery:

  • History of previous lumbar spine surgery
  • Indication for lumbar spine surgery is due to spinal cancer-related diagnosis
  • Need for urgent or emergent lumbar spine surgery

Inclusion Criteria for Candidates with Lumbar Failed Back Surgery Syndrome:

  • Chronic low back pain (+/- leg pain) for >= to 6 months duration after lumbar spine surgery (with or without instrumented fusion)
  • Low back pain severity is moderate to severe (Numerical Rating Scale [NRS] Score >=4)

Exclusion Criteria for Candidates with Lumbar Failed Back Surgery Syndrome:

  • Have a structural spinal lesion that would make them a current candidate for a revision lumbar spine surgery

Inclusion Criteria for Healthy Volunteers:

  • No major diseases or diagnoses influencing pain or function

Exclusion Criteria for Healthy Volunteers:

  • No chronic pain condition
  • Score 3 or greater on the 2011 FM Survey Criteria (i.e. individuals with very mild fatigue or sleep problems will be allowed to participate as this is extremely common in the general population)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Candidate for Lumbar Spine Surgery
Participants have been designated to be a candidate for lumbar spine surgery to treat chronic low back and/or leg pain and you have agreed to proceed with the surgery.
Lumbar Failed Back Surgery Syndrome
Participants have been diagnosed with having lumbar failed back surgery syndrome and have persistent and moderate-to-severe low back and/or leg pain for more than 6 months after a lumbar spine surgery.
Healthy Volunteer
Participants are a healthy volunteer wishing to participate in a research study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical pain severity
Time Frame: Change from Baseline to Month 6
Measured by the Brief Pain Inventory (BPI). The BPI scores are a numerical rating scale and range from 0 to 10. A score of 0 is equal to no pain and a score of 10 is equal to pain as bad as you can imagine.
Change from Baseline to Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROMIS (Patient-Reported Outcomes Measurement Information System)
Time Frame: Change from Baseline to Month 6
PROMIS measures to be included are Depression, Anxiety, Physical Functioning, Fatigue, Sleep Impairment, Emotional Support, and Social Participation. Each questionnaire usually has 4-16 response options ranging in value from one to five. The total raw score for a short form with all questions answered is the sum of the values of the response to each question. The total range of potential raw scores depends on the number of questions being asked, for example, a 6 item form would have a range from is 6 to 30. After the raw score is calculated, a T-score metric is used to convert the raw score to a T-score. On the T-score metric, a score of 50 is the mean of a relevant reference population and 10 is the standard deviation of that mean. For PROMIS measures, higher scores equals "more of the concept being measured", this could be a desirable or undesirable outcome, depending on the concept being measured.
Change from Baseline to Month 6
Oswestry Disability Index
Time Frame: Change from Baseline to Month 6
The Oswestry Disability Index will be used to assess low back pain. There are 10 sections on the index. Each section has a possible score of 5. The total possible range of scores is 0 to 50. A score of 0 indicates no pain. A score of 50 indicates the person is bed-bound or exaggerating their symptoms.
Change from Baseline to Month 6
2011 Fibromyalgia Survey
Time Frame: Change from Baseline to Month 6
A measure of symptom severity in fibromyalgia. There is a total range of scores from 0 to 31. The higher the score the more severe a person's symptoms.
Change from Baseline to Month 6

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Magnetic Resonance Imaging - Brain Regions and Pain Processing
Time Frame: Baseline
A subgroup of patients enrolled will also undergo four different neuroimaging procedures (all in one visit) to identify brain regions and associated neurotransmitters operative in pain processing and modulation.
Baseline
Quantitative Sensory Testing (QST) - Pressure pain sensitivity by Algometry
Time Frame: Baseline
Pressure pain sensitivity is measured by Algometry (measured at the trapezius and lumbar spine). It yields a pressure pain threshold value measured in kPA.
Baseline
Quantitative Sensory Testing (QST) - Pressure pain sensitivity by Multimodal Automated Sensory Testing
Time Frame: Baseline
Pressure pain sensitivity is measured by the Multimodal Automated Sensory Testing (MAST) System (measured at the thumbnail). It yields a pressure pain threshold value measured in kg/cm2.
Baseline
Quantitative Sensory Testing (QST) - Cuff Algometry
Time Frame: Baseline
Cuff Algometry as measured by a rapid cuff inflator (measured at the gastrocnemius muscle). It yields a deep pressure pain threshold as measured in mmHg.
Baseline
Quantitative Sensory Testing (QST) - Conditioned Pain Modulation (CPM)
Time Frame: Change from Post-stimulus test at Baseline visit to Pre-stimulus test at Baseline visit
Conditioned Pain Modulation as measured at the thumbnail using the MAST. It yields a numerical pain rating difference on a 0-100 numerical scale that can either be positive or negative called CPM magnitude. CPM magnitude will be calculated as the difference (post-pre) in the mean of the three pain ratings given to the test stimulus prior to the conditioning stimuli and the three pain ratings of the test stimulus given during the conditioning stimuli. A reduction in test stimulus rating by conditioning stimulation implies functional (inhibitory) CPM, and the degree of reduction expresses the efficiency of CPM.
Change from Post-stimulus test at Baseline visit to Pre-stimulus test at Baseline visit
Wind Up Ratio (WUR)
Time Frame: Baseline
Temporal Summation as measured at the forearm and the lumbar spine using a PinPrick Algometer. It yields a numerical pain rating score from 0-100 numerical scale that will then be used to calculate the Wind Up Ratio (WUR) which is the mean pain rating of three stimulus trains divided by the mean pain rating of a single stimuli. A WUR >1 indicates temporal summation.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Chadwick, MD, University of Kansas Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2018

Primary Completion (Actual)

April 20, 2023

Study Completion (Actual)

April 20, 2023

Study Registration Dates

First Submitted

February 8, 2018

First Submitted That Met QC Criteria

February 21, 2018

First Posted (Actual)

February 23, 2018

Study Record Updates

Last Update Posted (Estimated)

February 9, 2024

Last Update Submitted That Met QC Criteria

February 8, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00140263
  • 1K23GM123320-01 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

3
Subscribe